MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-12-31, MCK made $106,158M in revenue. $1,186M in net income. Net profit margin of 1.12%.

Income Overview

Revenue
$106,158M
Net Income
$1,186M
Net Profit Margin
1.12%
EPS
$9.59
Unit: Million (M) dollars
Revenue Breakdown
    • North American Pharmaceutical Se...
    • Oncology And Multispecialty Segm...
    • Medical Surgical Solutions Segme...
    • Others

Income Statement
2025-12-31
2025-09-30
2025-06-30
2025-03-31
Revenues
106,158 103,150 97,827 90,823
Cost of sales
102,473 99,608 94,548 87,184
Gross profit
3,685 3,542 3,279 3,639
Selling, distribution, general, and administrative expenses
2,030 2,074 2,196 1,975
Claims and litigation charges, net
0 2 0 0
Restructuring, impairment, and related charges, net
36 63 47 73
Total operating expenses
2,066 2,135 2,243 2,048
Operating income
1,619 1,407 1,036 1,591
Other income, net
74 62 64 -31
Interest expense
63 74 49 45
Income from continuing operations before income taxes
---1,515
Income before income taxes
1,630 1,395 1,051 -
Income tax expense
380 232 220 209
Income from continuing operations
---1,306*
Loss from discontinued operations, net of tax
---0*
Net income
1,250 1,163 831 1,306
Net income attributable to noncontrolling interests
64 53 47 46
Net income attributable to mckesson corporation
1,186 1,110 784 1,260
Basic EPS
9.63 8.95 6.28 10.072
Diluted EPS
9.59 8.92 6.25 10.016
Basic Average Shares
123,200,000 124,000,000 124,900,000 125,100,000
Diluted Average Shares
123,700,000 124,400,000 125,500,000 125,800,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
North AmericanPharmaceutical...$88,322M Oncology AndMultispecialty...$13,010M Medical SurgicalSolutions...$2,991M OperatingSegments-Prescription Technology...$1,500M Material ReconcilingItems$335M Revenues$106,158M (11.40%↑ Y/Y)Gross profit$3,685M (12.21%↑ Y/Y)Cost of sales$102,473M (11.37%↑ Y/Y)Operating income$1,619M (32.27%↑ Y/Y)Other income, net$74M (7.25%↑ Y/Y)Total operatingexpenses$2,066M (0.29%↑ Y/Y)Income before incometaxes$1,630M (32.95%↑ Y/Y)Interest expense$63M (-5.97%↓ Y/Y)Selling, distribution,general, and...$2,030M (0.10%↑ Y/Y)Restructuring, impairment, andrelated charges, net$36M (12.50%↑ Y/Y)Net income$1,250M (34.70%↑ Y/Y)Income tax expense$380M (27.52%↑ Y/Y)Net incomeattributable to mckesson...$1,186M (34.93%↑ Y/Y)Net incomeattributable to...$64M (30.61%↑ Y/Y)

mck_logo_blue-svg

MCKESSON CORP (MCK)

mck_logo_blue-svg

MCKESSON CORP (MCK)